Committee for Orphan Medicinal Products (COMP):3-4 November 2016
Date:
03/11/2016 to 04/11/2016
Location:
European Medicines Agency, London, UK
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
-
List item
Agenda - COMP agenda of the 3-4 November 2016 meeting (PDF/216.19 KB)
Draft
First published: 03/10/2016
Last updated: 03/10/2016 -
List item
COMP meeting report on the review of applications for orphan designation: November 2016 (PDF/176.19 KB)
First published: 14/11/2016
Last updated: 14/11/2016
EMA/COMP/676785/2016 -
List item
Minutes of the COMP meeting 3-4 November 2016 (PDF/282.23 KB)
Adopted
First published: 10/01/2017
Last updated: 10/01/2017
EMA/COMP/704981/2016